Chronic Hypertension and Pregnancy 2 (CHAP2) Pilot Project
Eligible age
14–89 yrs
Accepts
Women
Locations
1 state
Healthy volunteers
Yes
See if you qualify for this study
Answer a few quick questions about your location and health. Takes about a minute.
About this study
The CHAP2 study is designed to provide preliminary data for a larger multicenter study to assess whether treatment of stage 1 hypertension (HTN) in pregnancy improves maternal and or neonatal outcomes. The primary objective of this pilot study is to determine if anti-HTN treatment to BP\<130/80mmHg in pregnant patients with stage 1 HTN is associated with a difference in birthweight percentile at delivery. Patients with stage 1 hypertension in pregnancy will be randomized to BP goals of \<130/80mmHg or usual care to treatment only if BPs ≥140/90mmHg. For this pilot, the investigator will randomize a total of 74 eligible participants, 37 to active treatment to BP\<130/80mmHg and 37 to usual care.
Sponsor: University of Alabama at Birmingham
You may qualify if…
- ✓ Viable singleton gestation
- ✓ No fetal anomalies
- ✓ Blood pressures 130-139/80-89mmHg on two occasions at least 4 hours apart prior to 20 weeks gestation
- ✓ Planning to deliver at UAB Hospital
- ✓ No indication for pregnancy termination
- ✓ Receiving care at the UAB prenatal clinics
You may not qualify if…
- ✕ Declines Randomization
- ✕ Known diagnosis of chronic hypertension ( BP ≥ 140/90mmHg) or current antihypertensive medication use
- ✕ Fetal demise diagnosed prior to enrollment
- ✕ Known major structural of chromosomal abnormalities prior to enrollment
- ✕ Contraindication to first line antihypertensive (Nifedipine/ Labetalol)
- ✕ Comorbidities requiring BP goals \< 130/80mmHg
Where it's recruiting
Birmingham
Source: ClinicalTrials.gov · NCT05989581 · last updated 2026-08-11